Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Growth factor receptor PTK inhibitors in development by American Cyanamid

April 7, 1999

Schering-Plough seeks further E.U. approval for Temodal

April 7, 1999

FDA approves DepoCyt for treatment of lymphomatous meningitis

April 6, 1999

Celgene and NCI collaborate on thalidomide cancer trial

April 6, 1999

Noncardiotoxic anthracyclines disclosed by Gem

April 6, 1999

Phase II trials of first anticancer dioxolane nucleoside analogue begin

April 5, 1999

Aronex regains worldwide marketing rights to Atragen

April 1, 1999

Dihydropyridines for reversing MDR presented at Japanese scientific meeting this week

April 1, 1999

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

April 1, 1999

New microtubule-stabilizing agents developed at Schering

April 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...